Publications by authors named "Anna Buder"

Claim this Profile
V
Validation of a next-generation sequencing assay for the detection of EGFR mutations in cell-free circulating tumor DNA.
Regina Stitz, Anna Buder, Rene Silye, Bernhard Baumgartner, Franz Pühringer

Exp Mol Pathol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic Copy-Number Alterations in Plasma Circulating Tumor DNA from Advanced EGFR-Mutated Lung Adenocarcinoma Patients.
Anna Buder, Ellen Heitzer, Julie Waldispühl-Geigl, Sabrina Weber, Tina Moser

Biomolecules· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter study.
Luka Brcic, Thomas Klikovits, Zsolt Megyesfalvi, Berta Mosleh, Katharina Sinn, Anna Buder

Transl Lung Cancer Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients.
Klaus Hackner, Anna Buder, Maximilian J Hochmair, Matthaeus Strieder, Christina Grech

Clin Med Insights Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Allele Frequency of EGFR Mutations Predicts Survival in Advanced EGFR T790M-Positive Non-small Cell Lung Cancer Patients Treated with Osimertinib.
Anna Buder, Maximilian J Hochmair, Martin Filipits

Target Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
mutation tracking predicts survival in advanced -mutated non-small cell lung cancer patients treated with osimertinib.
Anna Buder, Maximilian J Hochmair, Ulrike Setinek, Robert Pirker, Martin Filipits

Transl Lung Cancer Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR.
Anna Buder, Ulrike Setinek, Maximilian J Hochmair, Sophia Schwab, Klaus Kirchbacher

Target Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib.
Maximilian J Hochmair, Anna Buder, Sophia Schwab, Otto C Burghuber, Helmut Prosch

Target Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 and PD-L1 Protein Expression Predict Survival in Completely Resected Lung Adenocarcinoma.
Bojan Zaric, Luka Brcic, Anna Buder, Anita Brandstetter, Jorun O Buresch

Clin Lung Cancer· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC.
Anna Buder, Maximilian J Hochmair, Sophia Schwab, Tatjana Bundalo, Peter Schenk

J Thorac Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential of liquid biopsies.
Anna Buder, Christian Tomuta, Martin Filipits

Curr Opin Oncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis